Greenberg Traurig adds three shareholders from Weil

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Greenberg Traurig adds three shareholders from Weil

A team of three patent litigation partners is leaving Weil Gotshal & Manges to join Greenberg Traurig’s Washington, DC office.

Mark Davis, Stephen Shahida and Ronald Pabis have agreed to join Greenberg Traurig as shareholders, although the exact date of the move has yet to be determined.

Davis, who focuses on IP rights and associated antitrust issues, will join the firm as chair of its International Trade Commission practice.

Pabis focuses on patent trials, licensing and other technology-related disputes. He also has experience in Section 337 investigations before the ITC.

Shahida focuses on patent disputes. Prior to joining Weil Gotshal, he co-headed the Washington, DC IP litigation practice at McDermott Will & Emery.



more from across site and SHARED ros bottom lb

More from across our site

VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Matteo Di Lernia, advocate at LCA Studio Legale, unpicks the CJEU’s ruling in M.M. Ristorazione v Villa Ramazzini, including its impact on litigation strategies
Gift this article